Cargando…

Antipsychotic medication for women with schizophrenia spectrum disorders

There are significant differences between men and women in the efficacy and tolerability of antipsychotic drugs. Here, we provide a comprehensive overview of what is currently known about the pharmacokinetics and pharmacodynamics of antipsychotics in women with schizophrenia spectrum disorders (SSDs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brand, Bodyl A., Haveman, Yudith R. A., de Beer, Franciska, de Boer, Janna N., Dazzan, Paola, Sommer, Iris E. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961338/ https://www.ncbi.nlm.nih.gov/pubmed/34763737 http://dx.doi.org/10.1017/S0033291721004591

Ejemplares similares

Antipsychotic medication for women with schizophrenia spectrum disorders – CORRIGENDUM
por: Brand, Bodyl A., et al.
Publicado: (2023)

Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders
por: Brand, Bodyl A., et al.
Publicado: (2023)

Estrogens in schizophrenia: progress, current challenges and opportunities
por: Brand, Bodyl A., et al.
Publicado: (2021)

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse
por: Sommer, Iris E, et al.
Publicado: (2022)

The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial
por: Brand, Bodyl A, et al.
Publicado: (2023)

S57. CHARACTERIZING COGNITIVE HETEROGENEITY IN INDIVIDUALS WITH A SCHIZOPHRENIA SPECTRUM DISORDER: A CLUSTER ANALYTIC APPROACH
por: Brand, Bodyl
Publicado: (2020)

Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol
por: Brand, Bodyl A., et al.
Publicado: (2020)

The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis
por: de Boer, Janna, et al.
Publicado: (2018)

Chronic Use of Antipsychotics in Schizophrenia: Are We Asking the Right Question?
por: Rubio, Jose M, et al.
Publicado: (2022)

Language disturbances in schizophrenia: the relation with antipsychotic medication
por: de Boer, J. N., et al.
Publicado: (2020)

T59. ACOUSTIC SPEECH MARKERS FOR SCHIZOPHRENIA
por: de Boer, Janna, et al.
Publicado: (2020)

Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study
por: Hoekstra, Sanne, et al.
Publicado: (2021)

Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis
por: Begemann, Marieke J., et al.
Publicado: (2020)

T73. COGNITIVE CLUSTERING IN SCHIZOPHRENIA SPECTRUM DISORDER AND THE ASSOCIATION WITH BRAIN VOLUME
por: Oomen, Priscilla, et al.
Publicado: (2020)

Genetic contributions to autism spectrum disorder
por: Havdahl, A., et al.
Publicado: (2021)

T216. VARIATION IN SIDE EFFECTS TO ANTIPSYCHOTIC TREATMENT ACROSS SCHIZOPHRENIA SPECTRUM DISORDERS
por: Susanne Neumeier, Maria, et al.
Publicado: (2020)

Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
por: Ringen, Petter Andreas, et al.
Publicado: (2019)

Central Auditory Processing Disorders in Individuals with Autism Spectrum Disorders
por: Ocak, Emre, et al.
Publicado: (2018)

Thought Disorder as a Neglected Dimension in Schizophrenia
por: Uzman Özbek, Simge, et al.
Publicado: (2021)

A commentary on “Antipsychotic-induced Parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders”
por: Salem, Amir, et al.
Publicado: (2015)

Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review
por: Sneller, Marius H., et al.
Publicado: (2021)

S136. CLASSIFYING SCHIZOPHRENIA USING PHONOLOGICAL, SEMANTIC AND SYNTACTIC FEATURES OF LANGUAGE; A COMBINATORY MACHINE LEARNING APPROACH
por: Voppel, Alban, et al.
Publicado: (2020)

Role of the gut microbiome in three major psychiatric disorders
por: Borkent, Jenny, et al.
Publicado: (2022)

Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis
por: Balijepalli, Chakrapani, et al.
Publicado: (2018)

Safety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia
por: Andrade, Chittaranjan, et al.
Publicado: (2009)

Turning the Spotlight on Apathy: Identification and Treatment in Schizophrenia Spectrum Disorders
por: Lyngstad, Siv Hege, et al.
Publicado: (2023)

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
por: Lähteenvuo, M., et al.
Publicado: (2021)

Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials
por: Pagsberg, A K, et al.
Publicado: (2014)

Acoustic speech markers for schizophrenia-spectrum disorders: a diagnostic and symptom-recognition tool
por: de Boer, J. N., et al.
Publicado: (2023)

Response to: A Commentary on “Antipsychotic-Induced Parkinsonism is Associated with Working Memory Deficits in Schizophrenia-Spectrum Disorders”
por: Potvin, Stéphane, et al.
Publicado: (2015)

Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in Switzerland
por: Reymann, Stephan, et al.
Publicado: (2022)

Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness
por: Drosos, Petros, et al.
Publicado: (2022)

Invited Perspective: Air Pollution and Autism Spectrum Disorder: Are We There Yet?
por: Raz, Raanan, et al.
Publicado: (2022)

Functional brain networks in the schizophrenia spectrum and bipolar disorder with psychosis
por: van Dellen, Edwin, et al.
Publicado: (2020)

The use of atypical antipsychotics in Bipolar Spectrum disorders
por: Grünze, H., et al.
Publicado: (2003)

Antipsychotics for irritability in children with Autism Spectrum Disorders
por: Muñoz Martinez, V., et al.
Publicado: (2022)

Antipsychotic agents: efficacy and safety in schizophrenia
por: de Araújo, Arão Nogueira, et al.
Publicado: (2012)

Antipsychotic Effects on Cortical Morphology in Schizophrenia and Bipolar Disorders
por: Feng, Ruiqi, et al.
Publicado: (2020)

Prediction of drop-out and functional impairment in recent-onset schizophrenia spectrum disorders
por: Mucci, A., et al.
Publicado: (2021)

Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study
por: Oliva, Vincenzo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r3dr55hvlh7tgm59535m2h3050